Hrt Financial LP Collegium Pharmaceutical, Inc Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Hrt Financial LP holds 102,651 shares of COLL stock, worth $2.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

102,651

Holding current value

$2.99 Million

% of portfolio

0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $3.22 Million - $4.01 Million	102,651 New	102,651 $3.97 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $1.56 Million - $2.04 Million	49,984 Added 102.84%	98,586 $3.83 Million
Q4 2023 Feb 09, 2024	SELL	$21.16 - $30.8 $908,271 - $1.32 Million	-42,924 Reduced 46.9%	48,602 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $268,474 - $307,044	12,646 Added 16.03%	91,526 $2.05 Million
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $295,155 - $336,360	14,015 Added 21.61%	78,880 $1.7 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $1.49 Million - $1.94 Million	64,865 New	64,865 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $888,470 - $1.16 Million	57,469 Added 406.6%	71,603 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $9,968 - $14,636	-701 Reduced 4.73%	14,134 $250,000
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $235,622 - $308,227	-13,699 Reduced 48.01%	14,835 $302,000
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $499,345 - $609,200	28,534 New	28,534 $533,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $386,488 - $552,841	-21,774 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $473,366 - $550,446	21,774 New	21,774 $514,000
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $321,109 - $435,374	-16,681 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $297,422 - $371,819	16,681 New	16,681 $334,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $995M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account